An update on serum amyloid A-LDL and its potential use for dyslipidemic patients receiving lipid-modulating treatment

Author： Kotani Kazuhiko  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.4, 2013-08, pp. : 419-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of orlistat in obese, dyslipidemic patients

By H Nelson Robert   M Miles John  

Future Lipidology, Vol. 1, Iss. 3, 2006-06 ,pp. : 267-273

Future Medicine

Access to resources Recommend Favorite

Electronegative LDL and Lipid Abnormalities in Patients Undergoing Hemodialysis and Peritoneal Dialysis

By  

Nephron Clin Pract, Vol. 108, Iss. 4, 2008-04 ,pp. : c298-c304

Karger

Access to resources Recommend Favorite

Preoperative medication use and its association with postoperative length of hospital stay in surgical oncology patients receiving comprehensive geriatric assessment

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 18, Iss. 1, 2018-01 ,pp. : 12-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

By Nakou E. S.   Filippatos T. D.   Georgoula M.   Kiortsis D. N.   Tselepis A. D.   Mikhailidis D. P.   Elisaf M. S.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1919-1929

Informa Healthcare

Access to resources Recommend Favorite

VISUAL POTENTIAL AND ITS USE IN GERIATRIC MENTAL HOSPITAL PATIENTS

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 11, Iss. 5, 1963-05 ,pp. : 472-484

John Wiley & Sons Inc

Access to resources Recommend Favorite